ReviewCureus2026
Medial Epicondylitis: A Review of Clinical Presentation, Diagnosis, and Management in the United Kingdom.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medial epicondylitis is a chronic tendinopathic disorder involving the flexor-pronator origin of the medial elbow, characterised by pain and functional limitation related to repetitive loading and microtrauma. The condition exemplifies the broader spectrum of overuse injuries that result from cumulative strain exceeding the capacity for tendon repair. Diagnosis relies primarily on clinical evaluation, with imaging modalities used selectively to define the extent of pathology or to exclude alternative causes of medial elbow pain. Management follows a structured, stepwise approach, centred on conservative therapy, including rest, physiotherapy, and graduated strengthening programmes that are supported by adjunctive interventions when symptoms persist. Surgical management is considered only in cases of chronic, treatment-resistant disease. Growing recognition of this condition in both community and inpatient populations highlights its relevance to multidisciplinary care and underscores the value of coordinated management strategies that combine clinical assessment, rehabilitation, and targeted use of imaging to optimise outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.